Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,

Detalhes bibliográficos
Autor(a) principal: Mariath,Luiza Monteavaro
Data de Publicação: 2021
Outros Autores: Kiszewski,Ana Elisa, Frantz,Jeanine Aparecida, Siebert,Marina, Matte,Ursula, Schuler-Faccini,Lavínia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000200155
Resumo: Abstract Background: Epidermolysis bullosa is characterized by cutaneous fragility and blistering. Historically, diagnosis is achieved by immunofluorescence mapping or transmission electron microscopy, both involving biopsy procedures. Genetic analysis, especially through next-generation sequencing, is an important tool for the diagnosis of this disease. In Brazil, access to diagnostic methods is limited, and consequently, most patients do not have an accurate diagnosis. Diagnosis allows the indication of prognosis and genetic counselling of the patient. Objectives: To evaluate the cost-effectiveness of a gene panel compared to immunofluorescence mapping and transmission electron microscopy by analyzing its benefits, limitations, and economic aspects. Methods: The gene panel included the 11 main genes associated with epidermolysis bullosa. The techniques were compared, assessing the average cost, advantages, and limitations, through a price survey and literature review. Results: Both immunofluorescence mapping and transmission electron microscopy require skin biopsy, are dependent on the investigator's expertise, and are subject to frequent inconclusive results. The gene panel is effective for the conclusive diagnosis of epidermolysis bullosa, presents high efficiency and accuracy, is economically feasible, and excludes the need for biopsy. The gene panel allows for prognosis, prenatal genetic diagnosis, and genetic counseling. Study limitations: It was not possible to find laboratories that perform transmission electron microscopy for epidermolysis bullosa diagnosis in Brazil. Conclusion: This study supports the gene panel as the first-choice method for epidermolysis bullosa diagnosis.
id SBD-1_a244029bbc59b56d4d8ac37f0f2a3e73
oai_identifier_str oai:scielo:S0365-05962021000200155
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,Genetic counselingDiagnosisEpidermolysis bullosaGenetic testingAbstract Background: Epidermolysis bullosa is characterized by cutaneous fragility and blistering. Historically, diagnosis is achieved by immunofluorescence mapping or transmission electron microscopy, both involving biopsy procedures. Genetic analysis, especially through next-generation sequencing, is an important tool for the diagnosis of this disease. In Brazil, access to diagnostic methods is limited, and consequently, most patients do not have an accurate diagnosis. Diagnosis allows the indication of prognosis and genetic counselling of the patient. Objectives: To evaluate the cost-effectiveness of a gene panel compared to immunofluorescence mapping and transmission electron microscopy by analyzing its benefits, limitations, and economic aspects. Methods: The gene panel included the 11 main genes associated with epidermolysis bullosa. The techniques were compared, assessing the average cost, advantages, and limitations, through a price survey and literature review. Results: Both immunofluorescence mapping and transmission electron microscopy require skin biopsy, are dependent on the investigator's expertise, and are subject to frequent inconclusive results. The gene panel is effective for the conclusive diagnosis of epidermolysis bullosa, presents high efficiency and accuracy, is economically feasible, and excludes the need for biopsy. The gene panel allows for prognosis, prenatal genetic diagnosis, and genetic counseling. Study limitations: It was not possible to find laboratories that perform transmission electron microscopy for epidermolysis bullosa diagnosis in Brazil. Conclusion: This study supports the gene panel as the first-choice method for epidermolysis bullosa diagnosis.Sociedade Brasileira de Dermatologia2021-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000200155Anais Brasileiros de Dermatologia v.96 n.2 2021reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1016/j.abd.2020.05.015info:eu-repo/semantics/openAccessMariath,Luiza MonteavaroKiszewski,Ana ElisaFrantz,Jeanine AparecidaSiebert,MarinaMatte,UrsulaSchuler-Faccini,Lavíniaeng2021-05-04T00:00:00Zoai:scielo:S0365-05962021000200155Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2021-05-04T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
title Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
spellingShingle Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
Mariath,Luiza Monteavaro
Genetic counseling
Diagnosis
Epidermolysis bullosa
Genetic testing
title_short Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
title_full Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
title_fullStr Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
title_full_unstemmed Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
title_sort Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach,
author Mariath,Luiza Monteavaro
author_facet Mariath,Luiza Monteavaro
Kiszewski,Ana Elisa
Frantz,Jeanine Aparecida
Siebert,Marina
Matte,Ursula
Schuler-Faccini,Lavínia
author_role author
author2 Kiszewski,Ana Elisa
Frantz,Jeanine Aparecida
Siebert,Marina
Matte,Ursula
Schuler-Faccini,Lavínia
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Mariath,Luiza Monteavaro
Kiszewski,Ana Elisa
Frantz,Jeanine Aparecida
Siebert,Marina
Matte,Ursula
Schuler-Faccini,Lavínia
dc.subject.por.fl_str_mv Genetic counseling
Diagnosis
Epidermolysis bullosa
Genetic testing
topic Genetic counseling
Diagnosis
Epidermolysis bullosa
Genetic testing
description Abstract Background: Epidermolysis bullosa is characterized by cutaneous fragility and blistering. Historically, diagnosis is achieved by immunofluorescence mapping or transmission electron microscopy, both involving biopsy procedures. Genetic analysis, especially through next-generation sequencing, is an important tool for the diagnosis of this disease. In Brazil, access to diagnostic methods is limited, and consequently, most patients do not have an accurate diagnosis. Diagnosis allows the indication of prognosis and genetic counselling of the patient. Objectives: To evaluate the cost-effectiveness of a gene panel compared to immunofluorescence mapping and transmission electron microscopy by analyzing its benefits, limitations, and economic aspects. Methods: The gene panel included the 11 main genes associated with epidermolysis bullosa. The techniques were compared, assessing the average cost, advantages, and limitations, through a price survey and literature review. Results: Both immunofluorescence mapping and transmission electron microscopy require skin biopsy, are dependent on the investigator's expertise, and are subject to frequent inconclusive results. The gene panel is effective for the conclusive diagnosis of epidermolysis bullosa, presents high efficiency and accuracy, is economically feasible, and excludes the need for biopsy. The gene panel allows for prognosis, prenatal genetic diagnosis, and genetic counseling. Study limitations: It was not possible to find laboratories that perform transmission electron microscopy for epidermolysis bullosa diagnosis in Brazil. Conclusion: This study supports the gene panel as the first-choice method for epidermolysis bullosa diagnosis.
publishDate 2021
dc.date.none.fl_str_mv 2021-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000200155
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000200155
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.abd.2020.05.015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.96 n.2 2021
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126424263688192